高睡眠症的评估:从症状到诊断,一个多维的方法
L Peter-Derex1, J-A Micoulaud-Franchi2, R Lopez3
1Centre for Sleep Medicine and Respiratory Diseases, Croix-Rousse Hospital, Hospices Civils de Lyon, Lyon 1 University, Lyon, France; Lyon Neuroscience Research Centre, PAM Team, INSERM U1028, CNRS UMR 5292, Lyon, France.
Revue neurologique
|August 10, 2023
概括
超眠症,以过度的嗜睡为特征,影响公众健康,需要仔细诊断. 准确的评估对于有效的治疗策略和管理相关风险至关重要.
科学领域:
- 神经学 神经学
- 睡眠医学 睡眠医学
- 公共卫生 公共卫生
背景情况:
- 超眠症是严重的公共卫生挑战,因为它的流行程度和对日常功能的影响.
- 它会影响学业/职业表现,增加事故风险,并造成相当大的社会经济负担.
- 准确的诊断对于确定适当的治疗干预措施至关重要.
研究的目的:
- 概述超眠症诊断的多方面的性质.
- 强调考虑各种症状及其严重程度的重要性.
- 讨论诊断工具的不断变化以及高睡眠症评估中的挑战.
主要方法:
- 使用秤,问卷和行为/神经生理测试进行调查.
- 评估超眠症的维度,承认主观和客观措施之间的潜在差异.
- 使用基于睡眠调节,流行病学和相关症状的病因学推理.
主要成果:
- 超眠症是复杂的,包括过度的白天嗜睡,需要睡眠,睡眠惯性和嗜睡.
- 区分生理和病理性超眠症需要仔细评估症状的严重程度,频率,背景和损伤.
- 调查必须使主观患者报告与客观数据相协调.
结论:
- 为了有效管理高睡眠症,需要进行全面的评估.
- 新工具的开发旨在提高事故风险的可访问性和预测准确性.
- 目前正在进行的睡眠生理学和技术研究不断完善超眠症调查方法.
相关概念视频
Management of Insomnia
281
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
281
Narcolepsy
140
Narcolepsy is a chronic sleep disorder characterized by pervasive, uncontrolled sleepiness and other sleep disturbances. One of its hallmark symptoms is an abrupt transition to REM sleep upon falling asleep, which causes symptoms typically associated with this phase to occur unexpectedly during wakefulness. These include the following symptoms, which typically last from a minute or two to half an hour.
140
Insomnia
107
Insomnia is a prevalent sleep disorder characterized by difficulty falling asleep, frequent awakenings during the night, and waking up too early without being able to return to sleep. People with insomnia often experience these disruptions at least three nights a week for at least one month. Chronic insomnia, which lasts for at least three months, can lead to increased anxiety, which in turn can worsen sleep difficulties, creating a cycle of sleeplessness and stress.
Multiple factors contribute...
Multiple factors contribute...
107
Substance Use Disorders Affecting Sleep
196
Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
Understanding the concepts of physical dependence,...
196
Sleepwalking and Sleep Talking
194
Somnambulism, commonly known as sleepwalking, involves individuals engaging in activities ranging from simple walking to more complex behaviors such as driving. Sleepwalking typically occurs during the slow-wave sleep stages 3 and 4 early in the night when the person is not dreaming, contradicting the myth that sleepwalkers are acting out their dreams.
Factors that increase the likelihood of sleepwalking include sleep deprivation and alcohol consumption. Contrary to common beliefs, it is safe...
Factors that increase the likelihood of sleepwalking include sleep deprivation and alcohol consumption. Contrary to common beliefs, it is safe...
194
Sedatives and Hypnotics Drugs: Miscellaneous Agents
202
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
202


